The Non-Malignant Channel is supported with funding from Agios (Gold).

The Thalassemia Channel is supported with funding from Agios (Gold).

VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

EHA 2022 | The demographics of patients with beta-thalassemia

Name: The demographics of patients with beta-thalassemia
Uploaded: 2022-06-10T00:00:00Z
Duration: 4 min 11 s
Description: Maria Domenica Cappellini, MD, University of Milan, Milan, Italy, discusses the importance of better understanding the demographics, clinical characteristics, and real-world treatment patterns among patients with beta-thalassemia. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.

Maria Domenica Cappellini • 10 Jun 2022

EHA 2022

Non-Malignant Thalassemia

Maria Domenica Cappellini, MD, University of Milan, Milan, Italy, discusses the importance of better understanding the demographics, clinical characteristics, and real-world treatment patterns among patients with beta-thalassemia. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.